RecruitingNot ApplicableNCT06330870
Brain Metastasis Development Mechanism in BCBM Patients
Evaluation of Brain Metastasis Development Mechanism in Patients With Breast Cancer With Brain Metastasis(BCBM)
Sponsor
Samsung Medical Center
Enrollment
30 participants
Start Date
Apr 6, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
This study is the experimental study for brain metastasis development mechanism in patients with breast cancer with brain metastasis
Eligibility
Sex: FEMALE
Inclusion Criteria2
- Breast cancer
- Brain metastasis curative surgery patient
Exclusion Criteria1
- Gamma Knife surgery patient
Interventions
PROCEDUREWGS/TME evaluation
WGS/TME evaluation with blood and brain metastasis tissue during brain metastasis curative surgery
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06330870
Related Trials
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828763 locations
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
NCT069260753 locations
Cardiac Outcomes With Near-Complete Estrogen Deprivation
NCT053096553 locations
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
NCT041190243 locations
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
NCT074780161 location